You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What is Trulicity® (dulaglutide) used for?
Trulicity (dulaglutide) is an injectable prescription medicine called a glucagon-like peptide-1 receptor agonist and is for people with type 2 diabetes.
See important safety information, including boxed warning, in the attached prescribing information.
Indications
Trulicity is an injectable prescription medicine that is used
- along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes, and
- to reduce the risk of major adverse cardiovascular events such as death, heart attack, or stroke in adults with type 2 diabetes with known heart disease or multiple cardiovascular risk factors.1
Enclosed Prescribing Information
Reference
1Trulicity [medication guide]. Indianapolis, IN: Eli Lilly and Company; 2025.
Date of Last Review: July 16, 2025